Michelle Leroux

Michelle Leroux is an Associate Director in Evidence Program Management at AstraZeneca, where they lead cross-functional study teams in clinical trials. With nearly 20 years of experience in clinical operations and development, Michelle has worked on phase I through IV trials across various therapeutic areas, including neurology and oncology. Previously, they held roles at institutions such as NoNO Inc, The George Institute for Global Health, and Population Health Research Institute, demonstrating a strong background in managing clinical trial processes and ensuring compliance with regulatory standards. Michelle holds a Bachelor’s Degree in Health Studies from the University of Waterloo and additional qualifications in project management and frontline management. They are a dual citizen of Canada and Australia.